UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 Current Report

     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  September 30, 1997
                                                  ------------------


                       Creative Medical Development, Inc.
                       ----------------------------------
             (Exact name of registrant as specified in its charter)


        Delaware                     33-75276                   68-0281098
        --------                     --------                   ----------
  (State or jurisdiction           (Commission                (IRS Employer
    of incorporation)              File Number)             Identification No.)


                   975 SE Sandy Blvd., Portland, Oregon 97214
                   ------------------------------------------
               (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code    (503) 230-8034
                                                      --------------


--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Item 5.  Other Events.

The  negotiations  for an equity  investment  and the Company's  acquisition  of
certain assets in exchange for common stock of the Company  pursuant to a letter
of intent dated July 30, 1997 terminated approximately October 1, 1997.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: October 30, 1997                    Creative Medical Development, Inc.


                                           By:  /s/  MICHAEL L. DEBONNY
                                               ---------------------------------
                                               Michael L. DeBonny, CEO
[{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 2225}]
{"company-data": {"conformed-name": "CREATIVE MEDICAL DEVELOPMENT INC", "cik": "0000919045", "assigned-sic": "3841", "irs-number": "680281098", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11725", "film-number": "97714617"}, "business-address": {"street1": "870 GOLD FLAT RD", "city": "NEVADA CITY", "state": "CA", "zip": "95959", "phone": "9162658222"}, "mail-address": {"street1": "870 GOLD FLAT ROAD", "city": "NEVADA CITY", "state": "CA", "zip": "95959"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 Current Report

     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  September 30, 1997
                                                  ------------------

                       Creative Medical Development, Inc.
                       ----------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                     33-75276                   68-0281098
        --------                     --------                   ----------
  (State or jurisdiction           (Commission                (IRS Employer
    of incorporation)              File Number)             Identification No.)

                   975 SE Sandy Blvd., Portland, Oregon 97214
                   ------------------------------------------
               (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code    (503) 230-8034
                                                      --------------

--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Item 5.  Other Events.

The  negotiations  for an equity  investment  and the Company's  acquisition  of
certain assets in exchange for common stock of the Company  pursuant to a letter
of intent dated July 30, 1997 terminated approximately October 1, 1997.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: October 30, 1997                    Creative Medical Development, Inc.

                                           By:  /s/  MICHAEL L. DEBONNY
                                               ---------------------------------
                                               Michael L. DeBonny, CEO